Claris Lifesciences informs about press release

08 May 2017 Evaluate

Claris Lifesciences has informed that Board of Director of the Company has approved the sale and transfer of the equity shares of Otsuka Pharmaceutical India (formerly knowns as Claris Otsuka) held by Claris Lifesciences Limited (CLL) in its meeting held on May 8, 2017 to Otsuka Pharmaceutical Factory, Inc for a consideration of $20 million. A Press Release being issued in this regards is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 263.55
Adani Enterprises 2156.70
Amrapali Industries 14.50
Rashi Peripheral 368.00
PDS 347.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×